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Abstract
Background: A major group of murine inhibitory receptors on Natural Killer (NK) cells belong to the Ly49 receptor family
and recognize MHC class I molecules. Infected or transformed target cells frequently downmodulate MHC class I molecules
and can thus avoid CD8
+ T cell attack, but may at the same time develop NK cell sensitivity, due to failure to express
inhibitory ligands for Ly49 receptors. The extent of MHC class I downregulation needed on normal cells to trigger NK cell
effector functions is not known.
Methodology/Principal Findings: In this study, we show that cells expressing MHC class I to levels well below half of the
host level are tolerated in an in vivo assay in mice. Hemizygous expression (expression from only one allele) of MHC class I
was sufficient to induce Ly49 receptor downmodulation on NK cells to a similar degree as homozygous expression, despite
a strongly reduced cell surface level of MHC class I. Co-expression of weaker MHC class I ligands in the host did not have any
further effect on the degree of Ly49 downmodulation. Furthermore, a single MHC class I allele could downmodulate up to
three Ly49 receptors on individual NK cells. Only when NK cells simultaneously expressed several Ly49 receptors and
hemizygous MHC class I levels, a putative threshold for Ly49 downmodulation was reached.
Conclusion: Collectively, our findings suggest that in interactions between NK cells and normal untransformed cells, MHC
class I molecules are in most cases expressed in excess compared to what is functionally needed to ensure self tolerance and
to induce maximal Ly49 downmodulation. We speculate that the reason for this is to maintain a safety margin for otherwise
normal, autologous cells over a range of MHC class I expression levels, in order to ensure robustness in NK cell tolerance.
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Introduction
Natural Killer cells are important in the defense against tumor
cells and virally infected cells. Their killing activity is regulated by
a balance between several activating and inhibitory receptors [1].
The activating receptors bind a diverse array of ligands, some of
which are stress-induced or virally encoded [2]. Many inhibitory
receptors expressed on NK cells recognize MHC class I molecules,
which are expressed on the majority of healthy cells. In case MHC
class I molecules are lost, NK cell killing may be induced. This
response is termed ‘‘missing-self’’ recognition [3], and may operate
as a defense against certain virus-infected and neoplastic cells on
which MHC class I is downmodulated in order to avoid CD8
+ T
cell recognition. Thus, a target cell can become NK cell sensitive
either by upregulation of ligands for activating NK cell receptors
or by downregulation of MHC class I [4,5,6]. These mechanisms
can operate independently but may also synergize to enhance NK
cell sensitivity [7].
The recognition of self MHC class I in the murine system
depends largely on Ly49 receptors. These receptors constitute a
family with both activating and inhibitory members, where the
inhibitory receptors have MHC class I as ligands [8]. A specific
interaction between an MHC class I molecule and an inhibitory
Ly49 receptor leads to transmission of a signal through the
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13174Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM), situated
in the cytoplasmic domain of Ly49 receptors. ITIM phosphory-
lation leads to recruitment of the phosphatase Shp-1, whose
activation leads to dephosphorylation of substrates in the
downstream propagation of activating signals [9].
The Ly49 receptor family contains several members with
distinct MHC class I-binding patterns. NK cells with full
functionality only mature if correct matching between Ly49
receptors with self MHC class I occur; presumably a mechanism to
ensure self tolerance [10,11]. Since the Ly49 and MHC class I loci
are genetically unlinked, an educational process is needed to
distinguish and promote NK cells with self MHC specificity
[12,13,14]. The mechanistic details of this process are poorly
understood. What is clear, however, is that there is a direct role for
MHC class I alleles in this process. Different MHC class I alleles
educate NK cells in a quantitatively different manner, i.e. they
have different educating impact on NK cells [15,16]. We have
recently shown that the self MHC class I alleles that are present in
an individual dictate the magnitude of response of individual NK
cells and control the quality of effector responses that each NK cell
performs upon stimulation. To explain this influence, we have
proposed a ‘‘rheostat model’’ of NK cell education [17,18].
Apart from interacting with MHC class I on other cells, Ly49
receptors also interact with MHC class I in their own cell
membrane, i.e. in cis [19]. By means of cis interaction, self MHC
class I molecules sequester Ly49 receptors, preventing them from
reaching the NK - target cell synapse [20]. As a consequence,
inhibition is reduced and the threshold for activation is lowered.
When Ly49receptorsinteract with MHCclassI,theircellsurface
levels are reduced. There are two reasons for this. Firstly, receptors
are internalized upon MHC class I ligand-binding in trans,a n d
secondly, Ly49 - MHC cis interactions masks the antibody binding
epitopes on the Ly49 receptors, which appears as a lower detected
expression level [19,21,22,23]. Regardless of the underlying
mechanism, this decrease in detected Ly49 receptor level represents
an indirect sign of a specific Ly49-MHC class I interaction, and,
as such, is useful for studies of Ly49 receptor specificity
[19,21,22,24,25,26]. We will from hereon refer to this decrease in
detected receptor expression level, as receptor downmodulation.
The findings mentioned above suggest that Ly49 interactions
with different MHC class I alleles are interpreted in a quantitative
way by the NK cell [16,17]. Another interesting question is
whether the MHC class I expression level of a given allele impose a
quantitative influence on Ly49 receptor signaling, especially in
interactions with normal autologous cells. Most studies attempting
to establish the role of MHC class I levels for NK cell inhibition
used transformed target cells with different MHC class I levels.
These studies came to the conclusions that the transition from
protection to loss of protection is not controlled continuously over
a range of MHC class I expression levels, but by a threshold effect
[13,27,28]. A recent paper showed that hemizygous expression of
MHC class I did not trigger killing by NK cells from MHC
homozygous mice, despite a significant reduction in expression of
MHC class I on the hemizygous target cells [29]. These results,
and the results from previous studies using tumor cell targets
[13,27,28], suggest that NK cells can tolerate a large reduction in
self MHC class I before they are triggered in vitro.
Whether NK cell responses in vivo are subject to a similar
regulation is not known. If they are, it is of great importance to
identify how much self MHC class I must be lost before NK cell
rejection of self cells occur in vivo. In the present paper, we have
studied the overall in vivo rejection of primary splenocytes
expressing different levels of surface MHC class I, aiming to
elucidate how much MHC class I is needed on the normal healthy
target cell to protect it from NK cell killing. We found that normal,
resting cells were tolerated by NK cells over a wide range of MHC
class I cell surface levels, rejection ocurring only when MHC class
I levels fell below approximately 20% of the host levels, supporting
a model in which a larger number of MHC class I molecules than
inhibitory receptors are present in vivo. Further supporting this
notion, a reduction of endogenous MHC class I levels down to
around half of the level in MHC homozygous mice still led to full
downmodulation of a number of investigated Ly49 receptors. In
addition, coexpression of several Ly49 receptors recognizing the
same MHC class I allele on individual NK cells did not reveal any
competition between different Ly49 receptors for MHC class I
ligands. Altogether, our results suggest that MHC class I molecules
are expressed in excess compared to what is needed for maximal
downmodulation of Ly49 receptors. We speculate that there is a
large margin in the amount of expressed MHC class I needed to
protect normal cells from being killed by NK cells, which may
reflect a need to secure self tolerance over a large range of natural
variations in MHC class I expression.
Materials and Methods
Mice
Mice were bred and maintained at the Department of
Microbiology and Tumor and Cell Biology (MTC, Karolinska
Institutet, Stockholm, Sweden). C57BL/6 (abbreviated B6, H-
2K
bD
b) and B6.Tap
2/2 mice were originally obtained from the
Bomholt Gaard breeding and research center (Ry, Denmark). D8
mice (transgenic for H-2D
d on B6 background) and L3 mice
(transgenic for H-2L
d on B6 background) have been previously
described [15,30]. B6.K
b2/2, B6.D
b2/2 and B6.K
b2/2D
b2/2
mice were generated as described [31,32,33]. Mice expressing H-
2D
d (B6.K
b2/2D
b2/2D
d+/+) or H-2L
d (B6.K
b2/2D
b2/2L
d+/+)
alone on B6 background were generated as described [16]. For
simplicity, the MHC class I molecules will be denoted by their
allelic (e.g. D
b,L
d) names only throughout the paper from hereon,
and mice will be denoted by the MHC alleles they do express. See
Table 1 for designations and full genotypes.
Table 1. Genotypes of the mice used in this study.
Designation in this study Genotype
MHC
2/2 B6.K
b2/2D
b2/2
Homozygote mice
K
bD
b+/+ B6
K
b+/+ B6.D
b2/2
D
d+/+ B6.K
b2/2D
b2/2D
d+/+
Hemizygote mice
K
bD
b+/2 B6.K
b+/2D
b+/2
K
b+/2 B6.K
b+/2D
b2/2
D
d+/2 B6.K
b2/2D
b2/2D
d+/2
Multiple MHC mice
K
bL
d B6.D
b2/2L
d+
K
bD
d B6.D
b2/2D
d+
D
bL
d B6.K
b2/2L
d+
D
bD
d B6.D
b2/2D
d+
K
bD
bL
d B6.L
d+
K
bD
bD
d B6.D
d+
doi:10.1371/journal.pone.0013174.t001
NK Tolerance for Low MHC I
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b and D
b (with one allele at each locus
expressing an MHC molecule, and the other being null, K
b+/2D
b+/2),
were generated by crossing B6 mice with B6.K
b2/2D
b2/2mice. Mice
hemizygous for either K
b or D
d alone was also generated by crossing
K
b+/+ or D
d+/+ mice, respectively, with B6.K
b2/2D
b2/2 mice. The
MHC class I cell surface expression in these hemizygous mice, relative
to the homozygotes, is shown in Figure 1.
Mice expressing single MHC class I alleles (homozygously) were
crossed to generate F1 generations with the following genotypes:
K
b+D
d,D
b+D
d,K
b+L
d and D
b+L
d [16]. It should be noted that the
breedings of double and triple MHC class I mice used in the
experiments for modeling of Ly49 downmodulation were set up as
alternatively hemizygote or homozygote of different MHC class I
alleles,and that consequently the expression levels of K
b,D
b and D
d
differed between the mice (Table S1). Interestingly, the expression
levels of L
d did not follow the gene dosage pattern demonstrated by
other alleles. However, as proposed by the experiments shown in
Figure 2, the lower expression levels of MHC class I in hemizygous
mice did not have any effect on Ly49 down-modulation, when
compared to homozygous expression (Figure S1).
CFSE labeling and in vivo killing of CFSE-labeled cells
The method for measuring in vivo NK cell mediated rejection by
CFSE labeling of the target cells has been previously described [6].
It is a quantitative method performed with resting, non-
proliferating targets and non-irradiated recipients. In brief, spleen
cells from syngeneic and test mice were stained with 0.3 and 3 mM,
respectively, of the dye 5,6-carboxyfluorescein diacetate succini-
midyl ester (CFSE; Molecular Probes). 10
7 cells of each type
(syngeneic control and test population) were mixed and co-injected
intravenously (i.v.) into the same recipients. After 18–24 hours
(8 hours in Figure 3), the spleens were taken out, single cell
suspensions were made and the relative number of cells in each
CFSE population was measured either by a FACScan or a LSRII
(BD Biosciences, Mountain View, CA, USA). In some experiments
blood was taken out from the tail vein every 2 hrs to analyze the
stability of the Mulv-stabilized B6.Tap
2/2 cells injected i.v. The
relative survival of CFSE
high cells compared to CFSE
low cells,
providing a quantitative estimate of missing self rejection, was
calculated as follows: (acquired number of CFSE
high cells in
sample/acquired number of CFSE
low cells in sample)/(acquired
number of CFSE
high cells in injection mix/acquired number of
CFSE
low cells in injection mix). At least 2000 control (CFSE
low)
cells were acquired for each sample. When stated, recipient mice
were given 2 mg tilorone analogue (T-8014 or T-7514; Sigma-
Aldrich, Stockholm, Sweden) orally one day before injection of
donor cells. Tilorone is an interferon-inducer, which in non-
irradiated recipients has similar effects to Poly I:C (our
observations and [34]). For NK cell depletions, 200 mg PK136
(anti-NK1.1, mouse IgG2a) or TMb-1 (anti-IL-2Rb, rat IgG2b)
were given intraperitoneally two days before the experiment.
PK136 and TMb-1 were purified from hybridoma supernatants
Figure 1. MHC class I expression in mice hemizygous or homozygous for MHC class I. Expression levels of MHC class I molecules in K
bD
b
mice (upper two panels), K
b-single mice and D
d-single mice (lower two panels), as measured by flow cytometry. Thick black, thin grey and
intermediate grey lines represent expression in hemizygous, homozygous and MHC class I-deficient mice, respectively. Figures show one
representative mouse out of 14 stained for each mouse strain.
doi:10.1371/journal.pone.0013174.g001
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similar NK depleting efficiency (our own unpublished observation).
Peptide-induced stabilization of K
b on B6.Tap
2/2 target
cells inoculated in vivo.
B6.Tap
2/2 splenocytes isolated and treated aseptically were
counted and pulsed over-night with 0.2–10 mM Moloney murine
leukemia virus (Mulv) peptide (SSWDFITV [35]) at 26uCi n
RPMI medium containing 2% Fetal Calf Serum. The stability of
K
b on the Mulv pulsed cells in vivo was tested in NK1.1 treated K
b
single mice (Figure S2A). In this representative experiment, the K
b
levels expressed by the Mulv pulsed B6.Tap
2/2 cells in the pre-
inoculate were 64% and dropped to 32% within 2 hours at 37uC,
relative to K
b-syngeneic splenocytes. The K
b levels were thereafter
maintained up to the end of the experiment, 6–8 hrs after
inoculation. For rejection experiments, Mulv-pulsed target cells
Figure 2. MHC class I homozygous mice fail to kill MHC hemizygous splenocytes in vivo. A–C) Inoculation of CFSE
high labeled MHC class I
hemizygous (white circles) or MHC class I-deficient (white squares) splenocytes as targets, and CFSE
low syngeneic controls, into the indicated MHC
class I homozygous recipient. Black symbols represent the corresponding recipient depleted of NK cells. D) Over-night rejection of CFSE labeled
K
b+/2D
b+/2 targets compared to syngeneic controls in tilorone treated, NK1.1 depleted or untreated K
b+/+D
b+/+ recipients. Graphs (A–C) show mean
values and standard deviations from 2–3 experiments with total n=10 (K
bD
b) and n=4 mice (K
b and D
d), while in D, data show one representative
out of 2 experiments performed (n=2 mice per group).
doi:10.1371/journal.pone.0013174.g002
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b-
single mice, together with a K
b-single control cell population
labeled with 0.6 mM CFSE. After 8 hrs, the spleens were taken out
and the ratio between these two populations was calculated as
described above.
Antibodies and FACS analysis
Splenocytes were isolated and NK cells were enriched by nylon
wool separation. Fc receptors were blocked by incubation with
2.4G2 (anti-FccRIII). Anti-NK1.1 (PK136) -FITC, -PE and
-PerCP, anti-CD3e-PerCP (145-2c11), PE-Cy5, anti-CD19
PerCP-Cy5.5 (1D3), anti-Ly49G2-APC (4D11), anti-Ly49I-PE
(YLI-90), anti-Ly49F-PE (HBF-719), anti-H-2K
b-FITC and -PE,
Anti-H-2K
b-biotin, anti-H-2D
b-FITC, and streptavidin-PE were
purchased from BD Biosciences (Stockholm, Sweden). Anti-Ly49A
(YE1/48) hybridoma was grown in our laboratory, protein G
purified and subsequently conjugated to Alexa633 (Molecular
Probes). Anti-Ly49C-biotin and hybridoma (4LO3311) were a
kind gift from Suzanne Lemieux. 4LO3311 supernatant was used
and secondary stained using an anti-mouse IgG3 PE-Cy7
(Southern Biotech). Anti-NK1.1 APC-Cy7 (PK136) and anti-
Ly49A biotin (YE1/48) were purchased from Biolegend. Conju-
gation kit QD605, Pacific Blue, the dead cell marker Vivid Aqua
and streptavidin QD565 were purchased from Invitrogen. Flow
cytometry was performed on a FACScan, FACSAria or an LSRII
Special Order System (BD Biosciences, Mountain View, CA,
USA) and analyses were made using the FlowJo (ThreeStar, CA)
or Cellquest softwares. For analysis of receptor expression, cells
were gated on lymphocytes (Forward Scatter/Side scatter) and on
NK1.1
+CD3e
2 cells. For analysis of Ly49 receptor expression
levels in NK cell subsets, conjugates and dead cells were excluded
(FSC-A/FSC-H) and Vivid
+ respectively, followed by NK
identification by CD19
2CD3e
2, NK1.1
+ gating. Exclusion of
Ly49D, NKG2A and Ly49I
+ cells were done and analysis of
Ly49A, -C and -G2 expressing subsets were made.
Downmodulation index
The Ly49 expression levels in single MHC class I and MHC
2/2
mice have been published [16]. The relative expression levels (E)
of Ly49 receptors in MHC class I-expressing mice compared to
MHC
2/2 mice were calculated from the fluorescence intensity
(FI) as: E=100 * (median FI)/(median FI in MHC
2/2 mice). A down-
modulation index (DMI) for each receptor was calculated from E
as: DMI=1002E.
Calculation of expected down-regulation values under
the additive, dominant, or average model
For mice expressing a combination of two or three MHC class I
molecules, we calculated the expected values using three different
models. In all these models, the DMI for each MHC molecule was
taken from the DMI of the respective single MHC mouse
expressing that molecule. The models were as follows: 1) The
expected value of DMI if the effects of different MHC molecules
were additive, defined for each mouse as: DMI (additive) = SUM of
DMIs of all MHC molecules in this mouse. For instance, the expected
DMI (additive) for Ly49C in K
bD
b mice was calculated as DMI in
D
b-single mice + DMI in K
b-single mice. 2) The expected value of
DMI if the effects of different MHC molecules were averaged,
defined for each mouse as: DMI (average) = AVERAGE of DMIs of
all MHC molecules in this mouse. 3) The expected value of DMI if
binding to the most downmodulating MHC class I dominates, i.e.
for each mouse: DMI (dominant) = MAX of DMIs of all MHC
molecules in this mouse. For instance, the expected DMI for Ly49C in
K
bD
b mice under the dominance model would equal the DMI in
K
b single mice.
Statistical analysis
Averages and standard deviations were calculated for measure-
ments presented in Figures 2, 3, 4, 5, and 6, including the expected
DMI values under the three above-described models. Significance
of the differences between experimental groups and between the
observed and expected values (in the modeling) was calculated
using the standard Student’s t-test. For comparisons between
multiple populations in the experiment with Ly49 receptor levels
on NK cell subsets, one-way ANOVA was used with Bonferroni’s
post test if p,0.05.
Results
MHC class I surface expression is sensitive to gene
dosage
MHC class I expression is co-dominant, which means that both
the paternal and maternal alleles are expressed. In accordance
with this, we noticed in earlier experiments that the MHC class I
surface expression level was lower in mice hemizyguous for a given
MHC class I allele compared to mice carrying the same allele in a
homozygous fashion. To investigate this phenomenon more
systematically, and to quantify it for the K
b and D
b alleles, we
crossed B6 mice with B6.K
b2/2D
b2/2 (MHC
2/2) mice to
Figure 3. In vivo NK cell rejection of cells with peptide-
stabilized MHC class I expression. K
b single mice were injected
with CFSE
high B6.Tap
2/2 cells unpulsed or pulsed with Mulv peptide,
mixed with CFSE
low syngeneic control cells. The cells were stained for K
b
at the time of inoculation, and the K
b MFI level in % of the syngeneic
controls was calculated. These values are indicated on the x axis. The
rejection was assessed in the spleen after 8 hrs, and is shown on the Y
axis. CFSE ratio between target cells and syngeneic controls was
calculated relative to the NK1.1 treated group in each experiment, to
compensate for inter-experimental variation. Each dot represents the
mean of 2 mice/group in each experiment, with total n=32 mice for the
Tap+Mulv groups and n=23 mice for unpulsed Tap
2/2 groups (NK
depleted and non-depleted). The dashed line indicates the minimal
amount of killing of unpulsed cells that occurred in any experiment.
Data in the graph were obtained from a total of 8 experiments. The
difference between rejection of unpulsed and Mulv pulsed cells was
statistically significant (P=0.0018 for all experiments with an induced K
b
expression of at least 23% of control, compared to NK1.1 controls in the
same experiments).
doi:10.1371/journal.pone.0013174.g003
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full genotypic names). Cell surface expression of K
b in K
b+/-D
b+/2
mice was reduced to 5364.8% of the levels in K
b+/+D
b+/+ mice
(Figure 1). The corresponding number for D
b was 71610%
(Figure 1).
To extend this analysisto anadditional MHCclassI allele,and to
test whether this finding was also seen in mice expressing a single
MHC class I allele, we crossed mice expressing either K
b or D
d as a
single MHC class I allele on B6 background, with MHC
2/2 mice,
to generate K
b+/2 and D
d+/2 mice. In these mice, MHC class I
levels were also reduced; in K
b+/2 mice to 59% and in D
d+/2 mice
to 42% relative to homozygous controls (Figure 1). Thus, for three
out of three analyzed MHC class I alleles, a gene dosage effect was
observed for MHC class I expression, suggesting that MHC class I
heavy chain transcripts represent a limiting factor in regulating
MHC class I expression. A recent study found a similar effect also
for a fourth allele, D
k [29].
Target cells hemizygous for MHC class I molecules are
not rejected by NK cells in MHC class I homozygous mice
We next tested the capability of K
b+/+D
b+/+ (wild-type B6) mice
to react to the decreased expression levels of MHC class I on target
cells from K
b+/2D
b+/2 mice. We used the previously described
method for rejection of CFSE-labeled cells and injected hemi-
zyguous K
b+/2D
b+/2 target cells into homozyguous K
b+/+D
b+/+
mice, together with syngeneic controls [6]. K
b+/+D
b+/+ mice were
unable to reject K
b+/2D
b+/2 cells to any measurable extent
(Figure 2A). This was seen over a time course of four days,
indicating that it was not due to a delayed rejection, but rather to
tolerance to these cells. In contrast, grafted cells completely lack-
ing MHC class I molecules were rapidly rejected (Figure 2A). A
similar result was seen for K
b+/2 and D
d+/2 target cells injected
into K
b+/+ and D
d+/+ mice respectively (Figure 2B and C).
We also tested the overnight rejection of K
b+/2D
b+/2 cells in
K
b+/+D
b+/+ mice pre-activated with the interferon-inducer tilorone.
This pre-treatment leads to a general increase in NK responsive-
ness, presumably via mechanisms similar to those operating in viral
infection [36]. Even in this experiment, K
b+/2D
b+/2 targets were
tolerated (Figure 2D). Thus, both resting and tilorone-activated NK
cells were insensitive to primary target cells with a down-regulation
ofsurfaceMHCclassI by42–59%,providingstrongevidencethat a
reduction in MHC class I expression of this magnitude is not
enough to break NK tolerance to self, even if NK cells are activated
by external stimulation.
In vivo NK cell rejection requires loss of more than 80%
of endogenuos MHC class I expression on target cells
We were surprised by the lack of rejection of normal cells
despite loss of up to 60% of self MHC class I molecules at the cell
surface. Since MHC class I-deficient cells are efficiently rejected,
we hypothesized that there must be a threshold of MHC class I
expression needed for protection against NK cell killing. This
threshold would lie below approximately 40% of normal levels. To
try to identify this threshold, we made use of Tap
2/2 mice. These
mice express low levels of peptide-empty MHC class I molecules,
which can however be stabilized at the cell surface by the addition
of exogenuous peptide [37]. We used a peptide (Mulv) derived
from the Moloney murine leukemia virus, which up-regulates K
b,
Figure 4. Ly49 expression levels in MHC class I hemizygote and homozygote mice. Ly49 expression on NK1.1
+CD3
2 cells in A)K
bD
b, B)K
b
and C)D
d mice. Filled grey histograms represent expression in MHC class I-deficient mice, black thick line expression in homozygous mice and grey
line in hemizygous mice. Data represents one out of two experiments performed. The bar graphs show expression level of Ly49A, -C, or –G2
presented as % of median fluorescence intensity compared to MHC
2/2 mice, gated on the positive population for each receptor. Data are the means
of a total of 4 mice in each group. Error bars show standard deviation.
doi:10.1371/journal.pone.0013174.g004
NK Tolerance for Low MHC I
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b, on B6.Tap
2/2 cells [35,38] (Figure S2B, time zero).
Overnight incubation of B6.Tap
2/2 splenocytes with 0.2–10 mM
Mulv peptide induced K
b cell surface expression of 10 to 80%
levels as compared to K
b+/+ cells. The induced K
b level varied
with the peptide concentration used, but also varied between
experiments with the same peptide concentration.
We next examined in vivo rejection of B6.Tap
2/2 cells with a
stabilized K
b expression in K
b+/+ mice (Figure 3). After 8 hrs,
rejection of Mulv-stabilized B6.Tap
2/2 cells was only seen when
the K
b induction was below 20% of the level in K
b+/+ mice
(Figure 3). When K
b was induced above that level, the cells were
protected from rejection, in most cases. The instability of the
peptide-pulsed MHC class I complexes in vivo (Figure S2)
prevented us from measuring the tolerance over a longer
time; when the rejection assay was prolonged to overnight,
peptide-induced K
b levels returned to Tap
2/2 background levels
and killing of peptide-stabilized cells also became apparent (data
not shown). A longer observation time would have been useful to
allow for better resolution between rejected and protected target
cells. However, even if rejection of unpulsed cells was relatively
small at 8 hours after injection, it was significant relative to
NK1.1-treated controls (Figure 3). It should also be noted that the
MHC class I level dropped during the time course of the
experiment. Thus, the actual threshold could be even lower than
the observed 20% of MHC class I induction, which would not be
possible to control with this experimental setup. We conclude
from this set of experiments that a surprisingly low number of self
MHC class I molecules, approximately 20% of wild type, is
sufficient to protect normal nontransformed cells from missing-
self rejection in vivo.
Figure 5. Modeling of the effect of having multiple MHC class I ligands on Ly49 downmodulation. Degree of Ly49A and -C
downmodulation in mice expressing more than one MHC class I, and different models for their combined downmodulating effect. The ‘‘observed’’
levels were measured on freshly isolated NK1.1
+ CD3
2 splenocytes. The expression is shown as Downmodulation Index (DMI), which means %
reduction of median fluorescence intensity compared to the MHC
2/2 mouse. Values are averages of 3–7 experiments. The modeled values show
expected DMI if the downmodulating effect of the MHC class I molecules were additive, dominant, or averaged. See Material and Methods for
calculations. Error bars show standard deviations.
doi:10.1371/journal.pone.0013174.g005
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class I levels in hemizygous mice
The surface expression level of Ly49 receptors are down-
modulated by MHC class I through a combination of receptor
internalization and cis-interactions [21,22]. To test how a decrease
in MHC class I levels would affect the degree of Ly49 receptor
downmodulation, we measured Ly49A and Ly49C cell surface
expression on splenic NK cells from MHC homozygous and
hemizygous mice. Ly49A levels did not differ between K
b+/2D
b+/2
and K
b+/+D
b+/+ mice and were only marginally, if at all, lower
when compared to MHC
2/2 mice (Figure 4A). Ly49C was strongly
downmodulated in both K
b+/2D
b+/2 and K
b+/+D
b+/+ mice when
compared to MHC
2/2 mice, but no significant difference was seen
between K
b+/2D
b+/2 and K
b+/+D
b+/+ mice (Figure 4A). In the
analysis of K
b-single and D
d-single mice, a similar pattern was
observed with onlyminordifferencesbetween micehemizygous and
homozygousfor the MHCallele(Figure 4B, C).Altogether, reduced
MHC class I expression in hemizygous K
bD
b,K
b and D
d mice did
not affect downmodulation of Ly49 receptors on NK cells,
suggesting that MHC class I molecules are present in excess of
Ly49 receptors at the cell surface of NK cells, at least when it comes
to the mechanisms that induce Ly49 receptor downmodulation.
Ly49 downmodulation is unaffected by the co-
expression of additional low affinity MHC class I ligands
To further test the idea that MHC class I ligands might be in
excess relative to Ly49 receptors, we examined how Ly49 receptor
levels were influenced by the presence of several MHC class I
alleles, each with a separate downmodulating capability on the
same Ly49 receptor. To this end, we fitted observed down-
modulation data to what would be expected by three different
theoretical models, as follows: 1) The addition of several down-
modulating MHC class I ligands would provide an additive effect
on Ly49 downmodulation, so that the Ly49 receptor would be
more downmodulated in the presence of multiple, compared to
one single MHC class I ligand. 2) The most downmodulating
MHC class I ligand would dominate, and the addition of weaker
MHC class I ligands would have no additional effect on the Ly49
receptor expression level. 3) A stochastic competition exists
between MHC class I molecules that would affect Ly49 down-
modulation, such that the total downmodulation would be an
average of the Ly49 downmodulating effects of individual MHC
class I molecules.
To test these possibilities, we used mice that express different
combinations of two or three MHC class I alleles [16]. Mice
expressing at least two MHC class I molecules, that individually
downmodulated the same Ly49 receptor, were chosen. To define
when an MHC class I molecule had a downmodulating effect, we
used the published statistically significant effects on Ly49 down-
modulation in single MHC class I mice [16]. The MHC class I
molecules that had a downmodulating effect in this study were D
b,
D
d, and L
d for Ly49A, as well as K
b,D
b, and D
d for Ly49C. In
Figure 5 (observed values), we show downmodulation of Ly49A
and Ly49C in mice expressing combinations of these MHC
molecules, as Down-modulation Indices (DMI). DMI of 0 means
no down-modulation and 100 is complete down-modulation of the
receptor. Next, we calculated the expected values under each of
the theoretical models delineated above (dominant, additive, or
averaged down-modulation, see Material and Methods for
calculations).
The dominant model most frequently fitted best to the observed
DMI (Figure 5). The average model could be statistically excluded
for Ly49C (p,0.05 in all cases), but not for Ly49A. The additive
model could not be statistically excluded for either receptor,
possibly due to the high standard deviations calculated for this
model. Yet, the overall pattern clearly suggested that a strongly
downmodulating MHC class I molecule dominated the effect on
Ly49 expression over any additional MHC class I molecules.
Figure 6. Expression levels of three D
d-specific Ly49 receptors
in NK cell subsets of hemi- and homozygous mice. Naive
splenocytes from D
d+/+ (grey boxes) and D
d+/2 (white boxes) mice,
stained ex vivo and gated on viable, CD3
2CD19
2NK1.1
+ cells negative
for NKG2A, Ly49D and Ly49I. Graphs show surface expression levels of
A) Ly49A, B) Ly49C and C) Ly49G2 in the indicated subset combination.
Data are combined from at least three independent experiments.
Comparisons between subsets within strains were done using one-way
ANOVA (solid lines) and between strains (dotted lines) using t-test.
P-values: * ,0,05.
doi:10.1371/journal.pone.0013174.g006
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effect lost this effect completely if co-expressed with a stronger
MHC class I ligand. This supports our dominance model above
and suggests that MHC class I molecules are indeed expressed in
excess in relation to the Ly49 receptors.
Coexpression of multiple Ly49 receptors on the same NK
cell does not lead to increased cell surface expression of
individual receptors
Downmodulation of Ly49 receptors by MHC class I can be
used to predict which MHC class I alleles bind which Ly49
receptors [16]. Using this readout, we have previously identified
D
d as a ligand for all three receptors Ly49A, Ly49G2 and Ly49C
[16]. This notion is supported by previous MHC class I tetramer
binding data from others [39] and also fits with the ability of D
d to
functionally educate NK cell subsets expressing either one of these
three receptors in isolation [40]. Given that Ly49A, Ly49G2 and
Ly49C are all downmodulated by D
d, a model in which MHC
class I is limiting for Ly49 receptor downmodulation would predict
that the cell surface expression level of at least one of those Ly49
receptors would be higher on NK cell subsets co-expressing these
receptors, as compared to subsets expressing only one of the
receptors. In contrast, if MHC class I molecules are present in
excess, no such effect would be seen, and all of these Ly49
receptors would remain the same in NK cells expressing one, two
or three of these receptors.
To test this prediction, we used a polychromatic flow cytometric
protocol to measure the geometric Mean Fluorescence Intensity,
geoMFI of Ly49A, Ly49C and Ly49G2 in all subsets expressing
these receptors. To minimize contributions from other inhibitory
receptors, NK cells expressing the receptors NKG2A and Ly49I
were excluded. In addition, we also excluded the activating
receptor Ly49D from the analysis, since this receptor binds D
d and
could therefore affect the result. The same analysis including
Ly49D
+ NK cells, however, revealed only minor changes in the
receptor levels, and the overall pattern remained (data not shown).
Our results show that none of the receptors Ly49A, Ly49G2 or
Ly49C were expressed to a higher extent on NK cell subsets co-
expressing multiple as compared to single Ly49 subsets (Figure 6,
compare boxes with same color). This finding is in concordance
with the hypothesis that MHC class I is expressed in excess of
Ly49 receptors. In fact, somewhat surprisingly, the expression of
Ly49A and Ly49C was in some cases even lower when
coexpressed with Ly49G2, than when expressed in isolation
(Figure 6A and 6B). We did note, however, higher expression of
both Ly49A and Ly49G2 in D
d+/2 versus D
d+/+ mice for some NK
cell subsets coexpressing one or two additional Ly49 receptors
(Figure 6A and C). Thus, while data within each strain support a
saturation effect of MHC class I on Ly49 receptor down-
modulation, the comparison between hemizygous and homozy-
gous mice suggest that MHC class I expression can be a limiting
factor for receptor downmodulation on cells expressing multiple
Ly49 receptors.
Discussion
In this study, we addressed the influence of MHC class I levels
on NK cell rejection of target cells, and on expression levels of
Ly49 receptors. We found that cells expressing only 42% of the
MHC class I level of the host on average are stably tolerated by
NK cells in vivo over as long as four days, suggesting a robust
tolerance over a range of MHC class I expression levels. It should
be noted that the CFSE-based rejection method used in this study
gives a quantitative measurement of rejection. Therefore, it is
unlikely that we would have failed to detect rejection, even if only
a small subset of the target population was killed.
Since tolerance to missing-self rejection was robust over a range
of MHC class I expression levels, our data suggest a threshold
effect for MHC class I on NK cell killing. A threshold effect has
previously been suggested in an experiment with human NK cell
clones and transformed targets [27]. It is also in line with the
recently presented results by Jonsson et al, showing that in vitro
killing is efficiently inhibited by ligands displaying moderate
affinity to Ly49A, and that killing by D
d homozygote NK cells
expressing Ly49A can be effectively inhibited by target cells
expressing D
d hemizygously [29]. Such a threshold response in the
effector stage could however be surprising given the recently
published quantitative effect induced by the expression of MHC-
Ly49 allelic pairs having different interaction strengths [16,17,18].
It was also not expected from earlier experiments suggesting that
Ly49 receptor downmodulation would act as a mechanism to
increase sensitivity to very small changes in MHC class I levels
[41]. However, there could be physiological relevance (and
thereby an evolutionary advantage) with a threshold, rather than
a directly quantitative correlation, between MHC class I levels and
inhibition. It is likely that the normal expression level of MHC
class I molecules differs slightly between different cell types, or
between different organs. Robust tolerance to such physiological
differences in MHC class I levels would be a safeguard against
triggering inadvertent autoimmune responses in the absence of
disease.
In fact, the lack of reaction even by tilorone-activated NK cells
emphasizes the idea of robust tolerance over a range of MHC
levels. This result suggests that external activation of NK cells is
not enough to break tolerance, and hence that further alterations
of the target cell itself are required to trigger NK cell killing. These
alterations could include upregulation of activating ligands,
downregulation of alternative inhibitory pathways [42,43], or
further downregulation of MHC class I. These alternatives are not
mutually exclusive; they could also work together to define what is
a target cell compared to normal cells.
We also measured the effects of MHC class I on Ly49
expression levels and obtained data in support of a saturation
model. First, our modeling showed that the effects of individual
MHC class I alleles on Ly49 receptor downmodulation were not
cumulative when several MHC class I alleles were coexpressed.
The reason for this was that a strongly modulating allele already
led to maximal downmodulation when expressed in isolation.
Secondly, Ly49 receptors were not expressed at higher levels on
NK cells expressing only one MHC allele, but several Ly49
receptors, on the same cell. This suggests that there was enough
MHC class I available to allow full downmodulation of all Ly49
receptors at the same time. Only when MHC class I expression
was limiting and several Ly49 receptors present at the same time,
such as on NK cells in D
d hemizyguous mice, did we observe
incomplete downmodulation of some Ly49 receptors. Altogether,
the results support the saturation model, but also suggest the
existence of a limit to this saturation.
An unexpected finding was that the Ly49C receptor, and to
some extent also Ly49A, was expressed at even lower levels on
cells coexpressing Ly49A, Ly49C and Ly49G2 in D
d mice. This
could be a sign that additional mechanisms controlling Ly49
surface levels are at play, apart from downmodulation. We do not
know at this stage if this would be an MHC-independent or MHC-
dependent effect. MHC-independent mechanisms may exist that
restrict the total number of Ly49 receptors at the NK cell surface.
One reason could for example be competition for available space
between Ly49 receptors in appropriate parts of the NK cell
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effect to limit the total extent of inhibition an NK cell receives,
something that has been proposed to account for the lower
frequency of NK cells with several self-specific Ly49 receptors
[44]. The mechanisms could in either case be either post-
transcriptional, leading to less Ly49 receptors reaching the cell
membrane, or increased internalization of some Ly49 receptors.
This is an intriguing possibility that would require further
investigations to be clarified.
MHC class I interactions with Ly49 receptors have three
measurable effects: Inhibition of NK cell activation, downmodula-
tion of Ly49 expression levels, and education of NK cells to learn
what is ‘‘self’’ MHC class I. These three effects could in turn be
mediated via two types of Ly49-MHC class I interactions: cis or
trans. In the case of inhibition of killing, it is obvious that the
interactions take place through trans [27]. For the other two, the
situation is less clear. It is known that Ly49 downmodulation to a
large extent is mediated through cis interactions [19,20,45], but
trans interactions could also play a role, at least when the NK cells
themselves do not express any MHC ligand [21,23,46,47,48]. The
role for trans and cis interactions in NK cell education is also
unclear. Chalifour et al suggested that cis interactions may be
required for NK cell education [20]. Most other models for NK
cell education have assumed a dominant role of trans interactions,
but the question is not very well addressed [10,11,17,23,49].
Acquisition of external MHC class I ligands from surrounding
cells, and subsequent internalization in the NK cells’ own
membranes, also blurs the borders between cis and trans
interactions [22,50,51]. MHC class I molecules originating from
external cells could thus theoretically mediate effects through cis
interactions on the NK cell itself.
Since inhibition of rejection and receptor downmodulation
may, at least partly, be mediated through different types of MHC-
Ly49 interactions (cis and trans), our data should not automatically
be interpreted as if the threshold effect seen in rejection of
hemizygous target cells, like receptor downmodulation, is also due
to saturation. Even though cis and trans interactions take place
using the same interaction sites on the Ly49 receptor, the avidity
could be different in these two structurally different interaction
processes, which would be supported by the reported differences in
interaction mode [52]. This could in turn affect the threshold at
which Ly49 receptors become saturated in the two different
situations. Thereby, our data do not exclude the possibility that
NK cells from homozygous mice actually do ‘‘sense’’ the lower
levels of MHC class I on hemizygous cells, resulting in some type
of altered intracellular signalling (affecting e. g. education, as
discussed further below). However, because thresholds for
activation are set higher, the NK cell still would not react with
an effector action when confronted with hemizygous cells. It is thus
not possible to conclude at this point whether or not tolerance to
target cells expressing low levels of MHC class I is due to
saturation of Ly49 receptors. However, Jonsson et al observed a
correlation between the amount of cis interaction and inhibition of
NK cell activation using MHC class I alleles having different
affinities for Ly49A, which would support a connection between
the amount of cis interaction and the degree of inhibition of
activation [29]. This is an important issue, e. g. in attempts to
manipulate NK cells to detect and react to putative target cells
[53], and would therefore be an intriguing question to address in
the future.
The third outcome of Ly49-MHC interactions, besides Ly49
downmodulation and inhibition of killing, is NK cell education
and tuning. We did not address questions regarding education in
this study. As for killing, precaution should be taken to interprete
our results on ‘‘saturation’’ concerning receptor downmodulation,
as also being valid for NK cell education. In addition to the
differences between cis and trans interactions discussed above,
education may also differ from receptor downmodulation and
target cell killing in other aspects. For instance, educational
interactions may take place at different times (during NK cell
maturation) or in a different environment (displaying other MHC
class I levels). Jonsson et al also studied education (or licensing).
Their results would conform to the saturation effect [29].
However, there are also indications in the opposite direction.
Studies in relation to the rheostat model, published by us [17,18]
and Joncker et al [54], indicate that MHC molecules may exert
additive effects during education. Our ongoing studies also
indicate that hemizygous MHC levels, may not be saturating in
the educational process (manuscript in preparation). This would be
in contrast to our finding that Ly49 downmodulation is saturated
by the most strongly binding MHC class I, and shows that the
degree of Ly49 downmodulation does not always correspond to
the educating impact. Furthermore, saturation of Ly49 down-
modulation in the presence of several MHC ligands was only
supported by our data when the MHC class I allele was a strongly
down-modulating one, as in the case of the K
b-Ly49C and D
d-
Ly49A pairs. In the case of interactions leading to weaker down-
modulations, such as D
d and D
b with Ly49G2, there was not such
a clear-cut picture, and no statistically significant conclusions could
be drawn (data not shown). The ‘‘threshold’’ in the saturating
MHC class I level could thus potentially be different for different
MHC-Ly49 pairs.
It should be noted that in the wild mouse population, due to the
large number of alleles present at the MHC class I locus, the
‘‘normal’’ situation would most often be heterozygous expression
of MHC class I. Quantitatively, this would correspond to
‘‘hemizygous’’ expression of each allele. It could therefore be that
the NK cell system is not evolutionarily adapted to homozygous
expression of MHC class I. Further work is needed in order to
explore this interesting possibility. To what extent the ‘‘down-
modulating effect’’ reflects the affinity of the MHC class I-Ly49
interaction is also not known. Clearly, surface plasmon resonance
or similar measurements of the affinities of different Ly49-MHC
class I pairs would be an advantage and bring progress to our
understanding of the system.
To conclude, we have demonstrated in this study that NK cells
are unable to sense a decrease by more than half of the MHC class
I expression level on normal, resting cells, at least when it comes to
Ly49 down-modulation as well as killing of target cells. In contrast
to what was previously thought, mature NK cells are thus
relatively insensitive to fluctuations in the expression levels of
MHC class I molecules on normal cells. This may be a safeguard
against aberrant reactions leading to autoimmunity, and may
imply that other alterations of target cells, such as upregulation of
activating ligands, or down-regulation of other redundant
inhibitory ligands, may be crucial for the activation of NK cells.
Supporting Information
Figure S1 Ly49 expression levels are not influenced by the
MHC expression level in multiple MHC mice. The MHC class I
expression level of the downmodulating allele in each case (x-axis)
is taken from Table S1. The left panel shows Ly49C expression.
The expression level of Ly49C (y-axis) is shown as a function of K
b
expression level (x-axis) in K
b+/+ and K
bL
d+/2 mice (squares), and
as a function of D
b expression in D
b+/+ and D
bL
d+/2 mice
(triangles). MHC expression levels are shown as a fraction of K
b
and D
b single MHC mice, respectively. The K
b+/+ and D
b+/+ mice
NK Tolerance for Low MHC I
PLoS ONE | www.plosone.org 10 October 2010 | Volume 5 | Issue 10 | e13174are connected to the expression in MHC
2/2 mice with a dotted
line. The right panel shows Ly49A expression. The expression as a
function of D
d expression level in D
d+/+ and K
bD
d+/2 mice
(circles) and the expression level as a function of D
b expression in
D
b+/+ and K
bD
b+/+ mice (triangles), as in A). The D
d+/+ and D
b+/+
mice are connected to the expression in MHC
2/2 mice with a
dotted line. If the Ly49 expression level were dependent on the
MHC expression level, the hemizygous mice would be expected to
fall on this line, since they only express approximately half of the
MHC levels of the homozygous mice. However, this is in at least 3
out of4 cases not the case.The exceptionis the expression ofLy49C
as a function of D
b expression, which is a very weak interaction and
therefore the amount of downmodulation is statistically uncertain.
Found at: doi:10.1371/journal.pone.0013174.s001 (0.12 MB
TIF)
Figure S2 Stability of MHC complexes at the cell surface after
pulsing with Mulv peptide. A) In vivo stability of Mulv peptide. K
b
single mice were treated with NK1.1 and injected with CFSE
labeled B6.Tap
2/2 cells pulsed with Mulv, along with K
b
syngeneic controls. Their K
b levels were analyzed in blood after
2, 4, and 6 hours, and in the spleen after 6 hours. The reason for
the increased expression of Kb on inoculated syngeneic cells
during the experiment is unknown. B) Peptide binding to K
b and
D
b and its stability tested in vitro. B6.Tap
2/2 cells were pulsed
with Mulv overnight at 26uC, washed and then put at 37uC for
different time durations followed by staining and flow cytometry
analysis of K
b and D
b.
Found at: doi:10.1371/journal.pone.0013174.s002 (0.14 MB TIF)
Table S1 MHC expression level in mice expressing two or three
MHC class I alleles. MHC expression levels are given as a fraction
of the expression in the respective single MHC mouse. In K
bD
bL
d,
K
bD
bD
d, and K
bD
b mice the K
b and D
b alleles were
homozygously expressed. For all other alleles and mice the
MHC was hemizygously expressed. Numbers in parenthesis
indicate standard deviations.
Found at: doi:10.1371/journal.pone.0013174.s003 (0.03 MB
DOC)
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